| Groves published research on the impact of [[COVID-19]] on [[influenza].((Groves, H. E., Piché-Renaud, P.-P., Peci, A., Farrar, D. S., Buckrell, S., Bancej, C., Sevenhuysen, C., Campigotto, A., Gubbay, J. B., & Morris, S. K. (2021). //The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study.// The Lancet Regional Health - Americas, 1, 100015. https://doi.org/10.1016/j.lana.2021.100015)) | Groves published research on the impact of [[COVID-19]] on [[influenza]].((Groves, H. E., Piché-Renaud, P.-P., Peci, A., Farrar, D. S., Buckrell, S., Bancej, C., Sevenhuysen, C., Campigotto, A., Gubbay, J. B., & Morris, S. K. (2021). //The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study.// The Lancet Regional Health - Americas, 1, 100015. https://doi.org/10.1016/j.lana.2021.100015)) |
| Groves received honoraria from [[pharmaceutical_companies:AbbVie]].((Groves, H. E., Papenburg, J., Mehta, K., Bettinger, J. A., Sadarangani, M., Halperin, S., & Morris, S. (2021). //1188. The Effect Of The COVID-19 Pandemic On Influenza-Related Hospitalization, Intensive Care Admission And Mortality In Canadian Children.// Open Forum Infectious Diseases, 8(Supplement_1), S685–S686. https://doi.org/10.1093/ofid/ofab466.1380)) | Groves received honoraria from [[pharmaceutical_companies:AbbVie]].((Groves, H. E., Papenburg, J., Mehta, K., Bettinger, J. A., Sadarangani, M., Halperin, S., & Morris, S. (2021). //1188. The Effect Of The COVID-19 Pandemic On Influenza-Related Hospitalization, Intensive Care Admission And Mortality In Canadian Children.// Open Forum Infectious Diseases, 8(Supplement_1), S685–S686. https://doi.org/10.1093/ofid/ofab466.1380)) |
